| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| MAR001 | MAR001; MAR-001 | Phase 2 Clinical | Mareas Therapeutic Services Inc | Hypertriglyceridemia | Details |
| Lipisense | Phase 1 Clinical | Lipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KG | Hypertriglyceridemia | Details | |
| A24110He | A24110He; A-24110-He | Phase 1 Clinical | Lipigon Pharmaceuticals AB | Hyperlipidemias; Hypertriglyceridemia | Details |